Related Experiment Video
Updated: Mar 22, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[New guidelines for screening and management of familial dyslipidemia]
Insights
Familial dyslipidemia, a genetic cause of early cardiovascular disease, is often missed. Early screening and management are crucial for preventing heart events in affected individuals.
Area of Science:
- Cardiology
- Genetics
- Public Health
Context:
- Familial dyslipidemia is a significant genetic factor for premature cardiovascular disease.
- Current diagnosis and treatment rates remain suboptimal.
- Prevalence estimates suggest familial hypercholesterolemia affects 1/200-300 individuals and familial combined hyperlipidemia impacts 1-3% of the population in Europe.
Purpose:
- To highlight the underdiagnosis and undertreatment of familial dyslipidemia.
- To emphasize the importance of screening for early detection.
- To outline optimal management strategies for familial dyslipidemia.
Summary:
- Familial dyslipidemia, a genetic condition leading to high cholesterol, frequently causes premature cardiovascular disease.
- Screening is vital, especially in childhood for those with a family history of early heart disease or severe lipid disorders.
- Management includes lifestyle changes, eliminating other cardiovascular risks, and targeted medication.
Impact:
- Improved early detection of familial dyslipidemia.
- Reduced incidence of premature cardiovascular events.
- Enhanced patient outcomes through tailored management strategies.
Abstract:
Familial dyslipidemia, a frequent genetic cause of premature cardiovascular disease, is still underdiagnosed and undertreated. According to recent European studies, the prevalence of familial hypercholesterolemia is higher than previously suspected and reaches 1/200-300 persons, while familial combined hyperlipidemia affects 1-3% of the population. Screening is important, as familial dyslipidemia often leads to cardiovascular event before 60 years of age, and usual scores of risk are not appropriate for these patients. Screening is recommended in childhood in case of family history of premature cardiovascular disease or severe hyperlipidemia in first degree relatives. Lifestyle modifications, eviction of any additive cardiovascular risk factor and tailored drug therapy are the cornerstones of an optimal management.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...

